Sep 18, 2011

Hope On The Horizon 2011: New Drugs for Alzheimer’s Disease

Drug discovery research defines the Alzheimer’s Drug Discovery Foundation. Their mission is accelerating new drugs to: prevent, treat, and ultimately cure Alzheimer's Disease.

Alzheimer's Reading Room

Leonard A. Lauder
The Second Annual Fall Luncheon and Symposium, Hope on the Horizon: New Drugs for Alzheimer’s Disease, will be held Wednesday, September 21, 2011, at Jumeirah Essex House, New York City.

Chaired by Leonard A. Lauder, with distinguished, Nobel Prize winner Dr. Eric Kandel as keynote speaker.

The Charles Evans Award for Excellence will be presented to Dr. Daniel Skovronsky, President and CEO of Avid Radiopharmaceuticals, Inc.

The program will focus on the urgency of finding breakthrough treatments to detect, prevent, and cure Alzheimer’s and other neurodegenerative diseases.

100% of contributions will go directly to fund innovative drug research for Alzheimer’s.

Go here to learn more about the Second Annual Fall Luncheon and Symposium, Hope on the Horizon: New Drugs for Alzheimer’s Disease.

The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to rapidly accelerating the discovery and development of drugs to prevent, treat and cure Alzheimer’s disease, related dementias and cognitive aging.

ADDF raises and awards funds to academic and biotechnology scientists conducting drug discovery research in this field.

ADDF uses a venture philanthropy model to bridge the worldwide funding gap between basic research and later-stage development, using any return on investment to support new research.

Since its inception, our organization has identified and participated in some of the most groundbreaking scientific programs in Alzheimer’s research currently in progress.

More Insight and Advice for Caregivers

Original content Bob DeMarco, the Alzheimer's Reading Room